The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
G Hoxhaj, BD Manning - Nature Reviews Cancer, 2020 - nature.com
The altered metabolic programme of cancer cells facilitates their cell-autonomous
proliferation and survival. In normal cells, signal transduction pathways control core cellular …
proliferation and survival. In normal cells, signal transduction pathways control core cellular …
Lipid metabolism reprogramming and its potential targets in cancer
Reprogramming of lipid metabolism is a newly recognized hallmark of malignancy.
Increased lipid uptake, storage and lipogenesis occur in a variety of cancers and contribute …
Increased lipid uptake, storage and lipogenesis occur in a variety of cancers and contribute …
Wogonin and its analogs for the prevention and treatment of cancer: A systematic review
The medicinal plant Scutellaria baicalensis, commonly known as Chinese skullcap or
Huang‐Qin, has been used as a traditional medicine for several thousand years. The roots …
Huang‐Qin, has been used as a traditional medicine for several thousand years. The roots …
Lipid metabolism in cancer progression and therapeutic strategies
Y Fu, T Zou, X Shen, PJ Nelson, J Li, C Wu, J Yang… - MedComm, 2021 - Wiley Online Library
Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty
acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy …
acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy …
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
P Icard, S Shulman, D Farhat, JM Steyaert… - Drug Resistance …, 2018 - Elsevier
Cancer cells employ both conventional oxidative metabolism and glycolytic anaerobic
metabolism. However, their proliferation is marked by a shift towards increasing glycolytic …
metabolism. However, their proliferation is marked by a shift towards increasing glycolytic …
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway
J Chen, C Ding, Y Chen, W Hu, C Yu, C Peng, X Feng… - Cancer letters, 2021 - Elsevier
Lipid metabolic reprogramming plays a pivotal role in hepatocellular carcinoma (HCC)
development, but the underlying mechanisms are incompletely characterized. Long chain …
development, but the underlying mechanisms are incompletely characterized. Long chain …
Targeting AKT/mTOR in oral cancer: mechanisms and advances in clinical trials
Oral cancer (OC) is a devastating disease that takes the lives of lots of people globally every
year. The current spectrum of treatment modalities does not meet the needs of the patients …
year. The current spectrum of treatment modalities does not meet the needs of the patients …
ATP citrate lyase: A central metabolic enzyme in cancer
ACLY links energy metabolism provided by catabolic pathways to biosynthesis. ACLY,
which has been found to be overexpressed in many cancers, converts citrate into acetyl-CoA …
which has been found to be overexpressed in many cancers, converts citrate into acetyl-CoA …
[HTML][HTML] Influence of cholesterol on cancer progression and therapy
SS Mayengbam, A Singh, AD Pillai, MK Bhat - Translational oncology, 2021 - Elsevier
Cholesterol is a fundamental molecule necessary for the maintenance of cell structure and is
vital to various normal biological functions. It is a key factor in lifestyle-related diseases …
vital to various normal biological functions. It is a key factor in lifestyle-related diseases …
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism
C Granchi - European journal of medicinal chemistry, 2018 - Elsevier
ATP citrate lyase (ACLY) is a cytosolic homotetrameric enzyme that catalyzes the conversion
of citrate and coenzyme A (CoA) to acetyl-CoA and oxaloacetate, with the simultaneous …
of citrate and coenzyme A (CoA) to acetyl-CoA and oxaloacetate, with the simultaneous …